| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.006 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |